Unsupported Browser
The American College of Surgeons website is not compatible with Internet Explorer 11, IE 11. For the best experience please update your browser.
Menu
Become a member and receive career-enhancing benefits

Our top priority is providing value to members. Your Member Services team is here to ensure you maximize your ACS member benefits, participate in College activities, and engage with your ACS colleagues. It's all here.

Become a Member
Become a member and receive career-enhancing benefits

Our top priority is providing value to members. Your Member Services team is here to ensure you maximize your ACS member benefits, participate in College activities, and engage with your ACS colleagues. It's all here.

Become a Member
ACS
Literature Selections

POEM Yields Superior Results for Gastroparesis Versus Laparoscopic Gastric Electrical Stimulator

Selection prepared by Christopher DuCoin, MD, FACS

November 4, 2025

acs-store-journalperiodical.jpg

Shim SH, Cheng J, Yu Haitong, et al. Endoscopic Peroral Pyloromyotomy vs Laparoscopic Gastric Electrical Stimulator for Gastroparesis: A Propensity-Matched Multicenter Trial. J Am Coll Surg. October 2025.

This multicenter, propensity-matched trial provides valuable comparative data on two procedural approaches for medically refractory gastroparesis: endoscopic peroral pyloromyotomy (POP/G-POEM) and laparoscopic gastric electrical stimulation (GES). 

The study included 226 matched patients (113 per group) and found that POP significantly reduced operative time (28.9 min. versus 95.6 min., p < 0.001), estimated blood loss (2.75 mL vs. 10.9 mL, p < 0.001), and hospital stay (0.5 days vs. 2.4 days, p < 0.001) compared to GES. Both procedures had similar immediate complication rates and short-term safety profiles, making POP a less invasive and lower-morbidity option for this complex patient group.

From an outcomes standpoint, surgeons can appreciate that POP yielded stronger functional and symptomatic improvement. The Gastroparesis Cardinal Symptom Index (GCSI) decreased by 37.2% (from 3.5 to 2.2; p < 0.001), crossing below the symptomatic threshold of 2.6. Gastric emptying improved comparably between the groups—from 39.9% to 21.7% retention after GES and 39.7% to 20.5% after POP—but recurrence of symptoms was markedly lower following POP (41.6% vs. 78.8%, p < 0.001).

Despite similar 1-year reintervention rates (9.7% vs. 14.2%), Kaplan–Meier analysis showed that GES patients required more long-term corrective procedures, often due to device malfunction or symptom relapse.

Surgeons considering procedural sequencing can interpret this as evidence supporting a “POP-first” approach, reserving GES for select or secondary cases. The shorter operative duration, lower morbidity, and fewer recurrences make POP especially attractive for multidisciplinary teams focused on optimizing recovery and minimizing hospital resource use. The study’s large, matched sample and multicenter design strengthen its implications for contemporary surgical decision-making in gastroparesis management.